Stock Events

Stock Events

Ovid Therapeutics (1OT.F) Q2 2026 Earnings

12MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.15

-0.11

-0.08

-0.05

Details

Expected EPS

-0.10524888067

Actual EPS

-0.1022388

Surprise EPS

0

Surprise Percent

+2.86%

Description

Ovid Therapeutics (1OT.F) has reported earnings of -0.1022388 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.